Panther Biotech (PBYA) Granted FDA Pre-IND Meeting for TRF-DOX
Tweet Send to a Friend
Panther Biotechnology, Inc. (OTC: PBYA) announced that a Pre-Investigational New Drug (Pre-IND) meeting with the Divison of Oncology Products 1 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE